(RTTNews) - Labcorp Holdings Inc. (LH), a provider of innovative and comprehensive laboratory services, on Thursday announced that it had agreed to acquire select assets of BioReference Health, a subsidiary of OPKO Health Inc. (OPK).

Labcorp To Acquire BioReference Health Assets; OPKO Shares Rise 7.35% 

LH expands specialty testing and consumer services through acquisitions, partnerships and AI, while reimbursement and cost risks remain.

Is This the Right Time to Add Labcorp Stock to Your Portfolio?

The S&P 500 Index ($SPX ) (SPY ) closed unchanged on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.36%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%.  December E-mini S&P futures (ESZ26 ) fell -0.02%, and December E-mini Nasdaq futures...

Stocks Settle Mixed as Chipmakers Climb and Financial Stocks Fall

The S&P 500 Index ($SPX ) (SPY ) is up by +0.09% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.52%.  December E-mini S&P futures (ESZ26 ) are up +0.05%, and December E-mini...

Stocks Supported as Crude Oil Prices Ease

The S&P 500 Index ($SPX ) (SPY ) is up by +0.01% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down by -0.41%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.43%.  December E-mini S&P futures (ESZ26 ) are up +0.03%, and December E-mini...

Stocks Mixed as Crude Oil Prices and Financial Stocks Fall

Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.

TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing service, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, it offers digital pathology solutions, a pathology platforms that support the digitization, centralized review, and sharing of pathology slides; provider and payer digital platforms, an online applications for providers, MCOs, and ACOs; online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; and Generative AI enabled Test Selection, a generative AI enabled tool. It serves clients, third party, medicare/medicaid, patients, pharmaceutical, biotechnology, medical device, diagnostic companies, and CROs. It has a strategic collaboration with the Children's Hospital of Philadelphia to accelerate the discovery, development, and availability of pediatric diagnostics; a strategic alliance with the National Association of Community Health Centers to support current and emerging clinical leaders through the NACHC Leadership Exchange for Chief Medical Officers; and Alliance for Clinical Trials in Oncology to advance national clinical trial for patients diagnosed with colorectal cancer. The company was founded in 1995 and is headquartered in Burlington, North Carolina.

Labcorp Holdings Inc. News